Cargando…

Applications of Aptamers in the Diagnosis and Treatment of Ovarian Cancer: Progress From 2016 to 2020

Nucleic acid aptamers are short single-stranded DNA or RNA oligonucleotides selected from a random single-stranded nucleic acid library using systematic evolution of ligands by exponential enrichment technology. To allow them to bind to molecular targets with the same specificity and precision as th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Luoshan, Li, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473910/ https://www.ncbi.nlm.nih.gov/pubmed/34589111 http://dx.doi.org/10.3389/fgene.2021.683542

Ejemplares similares

Computable structured aptamer for targeted treatment of ovarian cancer
por: Ruan, Luoshan, et al.
Publicado: (2023)

Current Progress of RNA Aptamer-Based Therapeutics
por: Zhou, Jiehua, et al.
Publicado: (2012)

The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer
por: Chen, Biqing, et al.
Publicado: (2023)

Molecular Application of Aptamers in the Diagnosis and Treatment of Cancer and Communicable Diseases
por: Molefe, Philisiwe Fortunate, et al.
Publicado: (2018)

Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics
por: Tong, An, et al.
Publicado: (2023)

Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis
por: Liu, Jinhui, et al.
Publicado: (2019)

Progress in research on the role of exosomal miRNAs in the diagnosis and treatment of cardiovascular diseases
por: Xu, Jinyu, et al.
Publicado: (2022)

Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy
por: Han, Jing, et al.
Publicado: (2020)

Effects of acupuncture treatment on microRNAs expression in ovarian tissues from Tripterygium glycoside-induced diminished ovarian reserve rats
por: Lu, Ge, et al.
Publicado: (2022)

ML323 suppresses the progression of ovarian cancer via regulating USP1-mediated cell cycle
por: Song, Baozhi, et al.
Publicado: (2022)

Exploration of the Role of m(6) A RNA Methylation Regulators in Malignant Progression and Clinical Prognosis of Ovarian Cancer
por: Wei, Qinglv, et al.
Publicado: (2021)

A Novel Six-Gene Signature for Prognosis Prediction in Ovarian Cancer
por: Pan, Xin, et al.
Publicado: (2020)

Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer
por: Costello, Andrea M., et al.
Publicado: (2021)

Screening of aptamers and their potential application in targeted diagnosis and therapy of liver cancer
por: Zhang, Guo-Qing, et al.
Publicado: (2019)

Diagnosis of Ovarian Neoplasms Using Nomogram in Combination With Ultrasound Image-Based Radiomics Signature and Clinical Factors
por: Qi, Lisha, et al.
Publicado: (2021)

Editorial: Translational medicine in the diagnosis and treatment of cancer based on oncogenetics: from bench to bedside
por: Cao, Rui, et al.
Publicado: (2023)

Aptamer Nanomaterials for Ovarian Cancer Target Theranostics
por: Zhao, Jing, et al.
Publicado: (2022)

Using RNA Sequence and Structure for the Prediction of Riboswitch Aptamer: A Comprehensive Review of Available Software and Tools
por: Antunes, Deborah, et al.
Publicado: (2018)

Molecular basis of epigenetic regulation in cancer diagnosis and treatment
por: Tulsyan, Sonam, et al.
Publicado: (2022)

Aptamers in Bordeaux, 24–25 June 2016
por: Toulmé, Jean-Jacques, et al.
Publicado: (2017)

Epigenomics of Ovarian Cancer and Its Chemoprevention
por: Chen, Huaping, et al.
Publicado: (2011)

Identification of Hub Genes Associated With Progression and Prognosis in Patients With Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2019)

Three Genes Predict Prognosis in Microenvironment of Ovarian Cancer
por: Guo, Ya, et al.
Publicado: (2020)

DNA Methylation and Hydroxymethylation in Cervical Cancer: Diagnosis, Prognosis and Treatment
por: Zhu, Hongming, et al.
Publicado: (2020)

The prevalence of germline pathogenic variants in Estonian colorectal cancer patients: results from routine clinical setting 2016–2021
por: Roht, Laura, et al.
Publicado: (2022)

Acute Myeloid Leukemia in Qatar (2010–2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes
por: El Omri, Halima, et al.
Publicado: (2020)

Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer
por: Sun, Xiaodan, et al.
Publicado: (2019)

Aptamer-based rapid diagnosis for point-of-care application
por: Futane, Abhishek, et al.
Publicado: (2023)

Identification of CD8(+) T Cell Related Biomarkers in Ovarian Cancer
por: Li, Ling, et al.
Publicado: (2022)

KRAS is a prognostic biomarker associated with diagnosis and treatment in multiple cancers
por: Zhao, Da, et al.
Publicado: (2022)

Next Generation of Ovarian Cancer Detection Using Aptamers
por: Abreu, Rayane da Silva, et al.
Publicado: (2023)

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
por: Cai, Xin, et al.
Publicado: (2021)

Identification of a Gene Signature of Cancer-Associated Fibroblasts to Predict Prognosis in Ovarian Cancer
por: Zeng, Li, et al.
Publicado: (2022)

DNA Aptamers in the Diagnosis and Treatment of Human Diseases
por: Zhu, Qinchang, et al.
Publicado: (2015)

Germline Copy Number Variation and Ovarian Cancer Survival
por: Fridley, Brooke L., et al.
Publicado: (2012)

Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
por: Huo, Xiao, et al.
Publicado: (2021)

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)

Blood Circulating miRNAs as Cancer Biomarkers for Diagnosis and Surgical Treatment Response
por: Filipów, Samantha, et al.
Publicado: (2019)

The diagnosis and treatment for a patient with cancer of unknown primary: A case report
por: Hu, Hong, et al.
Publicado: (2023)

Impacts of vitrification on the transcriptome of human ovarian tissue in patients with gynecological cancer
por: Gu, Ruihuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4unbne5pb2d11aucefbdoec47p